Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016981
Filing Date
2024-06-14
Accepted
2024-06-14 17:34:16
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06142024_090611.html 4  
1 form4-06142024_090611.xml 4 5941
  Complete submission text file 0001415889-24-016981.txt   7320
Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Goldberg Mark Alan (Reporting) CIK: 0001532475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 241046154

Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)